Stonebrook Private’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
137,983
+2,587
+2% +$62.6K 0.61% 36
2026
Q1
$3.28M Buy
135,396
+4,705
+4% +$114K 0.7% 35
2025
Q4
$3.17M Buy
130,691
+4,840
+4% +$118K 0.66% 34
2025
Q3
$3.06M Buy
125,851
+4,290
+4% +$104K 0.66% 40
2025
Q2
$2.95M Buy
121,561
+1,921
+2% +$46.3K 0.69% 38
2025
Q1
$2.89M Buy
119,640
+4,273
+4% +$103K 0.75% 41
2024
Q4
$2.76M Buy
115,367
+10,803
+10% +$260K 0.72% 37
2024
Q3
$2.55M Buy
104,564
+28,670
+38% +$691K 0.67% 39
2024
Q2
$1.8M Buy
75,894
+16,955
+29% +$401K 0.52% 49
2024
Q1
$1.4M Buy
58,939
+25,019
+74% +$596K 0.41% 58
2023
Q4
$812K Buy
+33,920
New +$792K 0.27% 70

Other funds holding IBDS

Stonebrook Private's IBDS Position: Q2 2026 in Review

Stonebrook Private increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 1.9% in Q2 2026, buying an estimated $62.6K and bringing the position to 137,983 shares worth $3.34M. The position accounts for 0.61% of the portfolio, ranked #36.

Stonebrook Private first reported a position in IBDS in Q4 2023 and has held it in 11 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Stonebrook Private held 137,983 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $3.34M as of Q2 2026.
  • Stonebrook Private bought 2,587 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $62.6K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.61% of Stonebrook Private's portfolio in Q2 2026, its #36 holding.
  • Stonebrook Private first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.